Literature DB >> 25413879

Anatomical regional differences in selenium levels in the human brain.

Patrícia Ramos1, Agostinho Santos, Nair Rosas Pinto, Ricardo Mendes, Teresa Magalhães, Agostinho Almeida.   

Abstract

The role of selenium in human brain physiology, as well as in aging and neurodegenerative processes, remains unclear. Thus, the aim of this study was to establish the "normal" (reference) levels for selenium in the human brain, as well as anatomical regional differences and age-related changes. Using inductively coupled plasma-mass spectrometry after sample microwave-assisted acid digestion, selenium levels were measured in 14 different areas of the brain of adult individuals (n = 42; 71 ± 12, range 50-101 years old) without a known history of neurodegenerative, neurological, or psychiatric disorders. In the whole data set (n = 588; 42 individuals × 14 brain areas), selenium levels ranged from 552 to 1435 ng/g, with a mean ± SD content of 959 ± 178 ng/g (dry weight basis). Selenium distribution across the different brain areas was heterogeneous, with the highest levels in the putamen, parietal inferior lobule, and occipital cortex and the lowest expression in the medulla and cerebellum. Selenium levels were unchanged with aging. Compared with the age-matched control group, significantly increased levels of selenium were found in the globus pallidus, superior temporal gyrus, and frontal cortex of Parkinson's disease (n = 1) and Alzheimer's disease (n = 2) patients. This study provides new data on the anatomical regional differences in selenium levels in the human brain, which will aid future interpretation of studies examining brain tissue affected by neurodegenerative (and other) brain diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25413879     DOI: 10.1007/s12011-014-0160-z

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  6 in total

1.  Integration of Imaging Genomics Data for the Study of Alzheimer's Disease Using Joint-Connectivity-Based Sparse Nonnegative Matrix Factorization.

Authors:  Kai Wei; Wei Kong; Shuaiqun Wang
Journal:  J Mol Neurosci       Date:  2021-08-19       Impact factor: 3.444

2.  Widespread Decreases in Cerebral Copper Are Common to Parkinson's Disease Dementia and Alzheimer's Disease Dementia.

Authors:  Melissa Scholefield; Stephanie J Church; Jingshu Xu; Stefano Patassini; Federico Roncaroli; Nigel M Hooper; Richard D Unwin; Garth J S Cooper
Journal:  Front Aging Neurosci       Date:  2021-03-03       Impact factor: 5.750

Review 3.  Selenium as an important factor in various disease states - a review.

Authors:  Marek Kieliszek; Iqra Bano
Journal:  EXCLI J       Date:  2022-07-05       Impact factor: 4.022

4.  Detection of Alzheimer's disease by displacement field and machine learning.

Authors:  Yudong Zhang; Shuihua Wang
Journal:  PeerJ       Date:  2015-09-17       Impact factor: 2.984

Review 5.  Selenium in the Therapy of Neurological Diseases. Where is it Going?

Authors:  Agnieszka Dominiak; Anna Wilkaniec; Piotr Wroczyński; Agata Adamczyk
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

Review 6.  A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?

Authors:  Gerwyn Morris; Michael Berk; Basant K Puri
Journal:  Mol Neurobiol       Date:  2017-05-17       Impact factor: 5.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.